Search
Displaying 21–30 of 1082 results
-
- May 18, 2025
- 10:00 a.m. (EST)
- 355 Water Street SE, Washington, DC 20003
VisionWalkSince its inception in the Spring of 2006, VisionWalk has raised over $71 million to fund sight-saving research. Join your VisionWalk community! Together, we step closer to fighting blinding diseases.
-
Well-prepared estate plan brings peace of mind—knowing your loved ones are cared for and your wishes will be honored. It also offers a unique opportunity to leave a lasting impact on a cause important to you.
-
D.C. Metro Chapter Volunteer Opportunities
The DC Chapter is growing! Join our young professionals events for the Foundation Fighting Blindness, or become a part of the Young Professionals Committee.
-
ARVO 2025 Highlight: J&J’s XLRP Gene Therapy Didn’t Meet Primary Endpoint in Phase 3 Clinical Trial
Research NewsDespite missing the primary endpoint, the treatment improved vision for some patients.
-
Research News
The company is planning a Phase 2/3 clinical trial for the therapy in late 2025.
-
Research News
Part B of the trial will enroll nine adult patients as well as three pediatric patients.
-
A Mother’s Vision of a More Inclusive World
Beacon Stories WellnessThis Mother’s Day, we’re celebrating Krystle — a beacon of creativity, courage, and community. Legally blind mom Krystle Boateng couldn’t find children’s books she could comfortably read to her sons, so she created her own. Through her publishing company, Inside Ability Book, she’s redefining accessibility in children’s books and empowering individuals and families navigating vision loss and other disabilities.
-
Research News
The company is currently enrolling patients in its Phase 2/3 VISTA Clinical Trial.
-
Eye on the Cure
The Eye on the Cure Podcast from the Foundation Fighting Blindness provides science information, news, and insights from the world of vision and retinal diseases. The podcasts are hosted by Ben Shaberman, vice president, science communications, and often include conversations with guests from the research and vision communities.
-
Eye on the Cure Podcast | Episode 85: Cindy Elden
Eye on the CureCindy Elden talks about her journey with Usher syndrome type 3 (USH3), the decades-long work and persistence of her non-profit, and the clinical trial it launched for an USH3 small molecule therapy.
